These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21127188)

  • 1. Competing cell clones in myeloproliferative neoplasm.
    Al-Kali A; Verstovsek S; Kantarjian H; Luthra R; Cortes J
    Blood; 2010 Dec; 116(23):5074-5. PubMed ID: 21127188
    [No Abstract]   [Full Text] [Related]  

  • 2. De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.
    Portell CA; Sekeres MA; Rogers HJ; Tiu RV
    Br J Haematol; 2012 Apr; 157(2):266-7. PubMed ID: 22150289
    [No Abstract]   [Full Text] [Related]  

  • 3. [Precursors of acute leukemia: myelodysplastic syndromes and myeloproliferative neoplasms].
    Kreipe HH
    Pathologe; 2011 Nov; 32 Suppl 2():271-6. PubMed ID: 22033685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia arising from polycythemia vera underwent reversion to chronic phase of myeloproliferative neoplasm status post chemotherapy: Biclonal myeloid neoplasms with genomic evidence of a common early hematopoietic progenitor.
    Zhao Y; Sotolongo G; Deak K; Wang E
    Hematol Oncol; 2021 Apr; 39(2):254-257. PubMed ID: 33137210
    [No Abstract]   [Full Text] [Related]  

  • 5. DNMT3A, TET2, and JAK2 mutations in polycythemia vera following long-term remission of secondary acute myeloid leukemia.
    Jain P; Verstovsek S; Wang W; Loghavi S; Torres HA; Estrov Z; Patel KP; Pemmaraju N
    Leuk Lymphoma; 2016 Aug; 57(8):1969-73. PubMed ID: 26700872
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?
    Björkholm M; Hultcrantz M; Derolf ÅR
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):141-53. PubMed ID: 25189725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for post-myelofibrosis acute myeloid leukemia: eradication of the leukemic clone but not the MPN clone.
    Verger E; Rattarittamrong E; Letort G; Raffoux E; Cassinat B; Kiladjian JJ
    Leuk Lymphoma; 2017 Mar; 58(3):749-751. PubMed ID: 27562925
    [No Abstract]   [Full Text] [Related]  

  • 8. Double transformation of a hematopoietic malignancy and severe associated thrombopathy. Case presentation and review of the literature.
    Cişleanu D; Onisâi M; Vlădăreanu AM; Găman M; Neagul AM; Bumbea H; Iova A; Baluţa C; Cazaceanu O; Begu M; Ilea A
    Rom J Intern Med; 2011; 49(2):137-44. PubMed ID: 22303605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemic transformation in three patients with polycythemia vera. Analysis of the clinicopathological features and N-ras gene mutation.
    Sakai H; Karasawa M; Okamoto K; Maehara T; Tsukamoto N; Murakami H; Naruse T; Morita K; Tsuchiya J
    J Med; 1996; 27(3-4):183-91. PubMed ID: 8982966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p53 induces leukemic transformation in a murine model of Jak2 V617F-driven polycythemia vera.
    Tsuruta-Kishino T; Koya J; Kataoka K; Narukawa K; Sumitomo Y; Kobayashi H; Sato T; Kurokawa M
    Oncogene; 2017 Jun; 36(23):3300-3311. PubMed ID: 28068330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant JAK2 V617F-positive polycythemia vera and B-cell chronic lymphocytic leukemia in three patients originating from two separate hematopoietic stem cells.
    Swierczek S; Nausova J; Jelinek J; Liu E; Roda P; Kucerova J; Jarosova M; Urbankova H; Indrak K; Prchal JT; Divoky V
    Am J Hematol; 2013 Feb; 88(2):157-8. PubMed ID: 23280542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion?
    Langabeer SE
    Eur J Intern Med; 2018 Jun; 52():e37-e38. PubMed ID: 29622375
    [No Abstract]   [Full Text] [Related]  

  • 13. JAK2-positive myeloproliferative neoplasm co-existing with systemic mastocytosis.
    Thachil J; Hawkins S; Woodcock B
    Br J Haematol; 2011 Mar; 152(6):675. PubMed ID: 21219299
    [No Abstract]   [Full Text] [Related]  

  • 14. Transformation of polycythemia vera to chronic myelogenous leukemia.
    Mirza I; Frantz C; Clarke G; Voth AJ; Turner R
    Arch Pathol Lab Med; 2007 Nov; 131(11):1719-24. PubMed ID: 17979493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera.
    Inano T; Araki M; Morishita S; Imai M; Yasuda H; Nitta H; Ito M; Edahiro Y; Ochiai T; Misawa K; Fukuda Y; Ohsaka A; Komatsu N
    Br J Haematol; 2019 Oct; 187(1):e27-e31. PubMed ID: 31418453
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up.
    Senín A; Fernández-Rodríguez C; Bellosillo B; Camacho L; Longarón R; Angona A; Besses C; Álvarez-Larrán A
    Ann Hematol; 2018 Mar; 97(3):443-451. PubMed ID: 29181548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of polycythemia vera to acute promyelocytic leukemia.
    Kajiguchi T; Simokawa T; Saito M; Takeyama H
    Int J Hematol; 2000 Dec; 72(4):520-1. PubMed ID: 11197225
    [No Abstract]   [Full Text] [Related]  

  • 18. Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?
    Godfrey AL; Nangalia J; Baxter EJ; Massie CE; Kent DG; Papaemmanuil E; Campbell PJ; Green AR
    Blood; 2014 Nov; 124(22):3332-4. PubMed ID: 25414437
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow findings in blast phase of polycythemia vera.
    Hidalgo López JE; Carballo-Zarate A; Verstovsek S; Wang SA; Hu S; Li S; Xu J; Zuo W; Tang Z; Yin CC; Medeiros LJ; Bueso-Ramos CE; Tang G
    Ann Hematol; 2018 Mar; 97(3):425-434. PubMed ID: 29285580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetically centered evolution in an example of myeloid malignancy.
    Adélaide J; Cervera N; Carbuccia N; Garnier S; Guille A; Mozziconnaci MJ; Devillier R; Chaffanet M; Vey N; Birnbaum D; Gelsi-Boyer V
    Am J Hematol; 2016 Sep; 91(9):E361-2. PubMed ID: 27299509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.